BTA
Click for more information
0.00% 57.0¢ biota holdings limited

peramivir failed in a clinical trial

  1. ahboy
    1,003 Posts.
    lightbulb Created with Sketch. 126
    clock Created with Sketch.
    09/05/09
    08:04
    Post #: 5113995
    Reports overnight says that "flu drug candidate (peramivir) failed in trial".

    http://www.businessweek.com/ap/financialnews/D98276PG0.htm

    This development is good for BTA but not good for the seasonal and swine flu battle.

    Lani here we come!
    BTA Price at posting: $1.12 Sentiment: None Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

BIO Biome posts record sales revenue of $13M in FY24 – up 80% vs pcp and higher than forecast
right-arrow Created with Sketch.
ITM iTech lifts MRE at Eyre Peninsula Graphite Project by 300%
right-arrow Created with Sketch.
AHK Ark Mines defines significant exploration target at Sandy Mitchell rare earths project
right-arrow Created with Sketch.
LRV Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%
right-arrow Created with Sketch.
LLL Leo Lithium announces major divestment of flagship Goulamina project to Ganfeng
right-arrow Created with Sketch.
NEWS Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker
right-arrow Created with Sketch.
watchlist Created with Sketch. Add BTA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.